Andrews & Springer LLC announces that it has filed a class action lawsuit on behalf of Northwest Biotherapeutics, Inc. ("NWBO") and minority shareholders in the Delaware Court of Chancery - Case No. 11179. NWBO is a biotechnology company focused on developing immunotherapy products to treat cancers more effectively than current treatments without toxicities of the kind associated with chemotherapies. 

The complaint alleges that NWBO's Board of Directors along with its CEO and Chairperson Linda Powers ("Powers") and entities under her control -- Toucan Capital Fund III, L.P., Toucan Partners LLC and Cognate Bioservices, Inc. ("Cognate") -- breached their fiduciary duties by causing the Company to convert some of Cognate's outstanding invoices and future invoices (for prior services provided to the Company) into NWBO equity at an unfair price at the expense of the Company and minority shareholders. 

Click here for a copy of the public version of the complaint.